Orion Corp. B Stock
Price
Target price
€68.75
€68.75
-0.640%
-0.45
-0.640%
-
13.07.26 / Tradegate
WKN: A0J3QM / Symbol: ORINF / Name: Orion / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Orion Corp. B Stock
Orion Corp. B shows a slight decrease today, losing -€0.450 (-0.640%) compared to yesterday.
Pros and Cons of Orion Corp. B in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Orion Corp. B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Orion Corp. B | -0.640% | -2.482% | 0.438% | 3.151% | 7.506% | 87.636% | 86.567% |
| Sihuan Pharmaceutical Holdings Group Ltd. | 7.030% | -18.860% | -10.194% | -27.734% | -29.389% | 11.446% | -68.960% |
| Swedish Orphan Biovitrum Ab | -0.770% | -3.121% | 2.919% | 62.246% | 35.417% | 136.229% | 164.211% |
| Recordati SpA | -0.190% | -0.583% | 0.688% | -5.969% | 5.393% | 19.236% | -2.846% |
News
Redwire Stock Is Up 80% in 2026. Is It Too Late to Buy?
Shares of Redwire (NYSE: RDW) have surged 80% so far in 2026. The company is benefiting from increased interest in the space sector, especially amid SpaceX's much-awaited initial public offering
Is Redwire Stock a Buy Ahead of the SpaceX IPO?
SpaceX is set to make its public market debut in June and is likely to be the largest initial public offering (IPO) on record. As the company gears up to go public, investors are beginning to pay
Orion Office REIT Q1 Earnings Call Highlights
Orion Office REIT (NYSE:ONL) said its first-quarter results reflected continued progress on leasing, asset sales and balance-sheet management, while its board and management continue to evaluate
